CARGOCONNECT-NOVEMBER 2020 - Flipbook - Page 31
laborate on the topnotch infrastructure,
facilities and products
designed especially to
support storage and
transport of temp-sensitive
products at Doha Airport
and across the airline’s
Through QR Pharma, we offer
our customers temperaturecontrolled air freight for pharmaceuticals and healthcare
products, with both active and
passive solutions in cold chain
logistics. A range of temperature-controlled containers
from various partners like Envirotainer, CSafe, DoKaSch,
Va-Q-Tec, and most recently,
hybrid containers from SkyCell have been made available
for pharma clients.
We have set robust pharma
standards and operating procedures at our hub as well as
other stations while also providing rigourous training to
our staff. The Hamad International Airport (HIA) cargo terminal operates in accordance
with the highest industry standards and is fully compliant
with good distribution practice
(GDP), providing a seamless
cool chain for temperaturesensitive pharmaceuticals.
We have also invested in
an airside Climate Control
Centre at HIA which was inaugurated around the time of
the blockade. The 2,470 sq mt
transit facility with storage
capacity of 156 ULDs and dual-zoned temperature-controlled rooms enhances our
ability to process high volumes of phar maceut icals
quickly, within a climate-controlled environment. It has an
estimated throughput capacity of 285,000 tonnes annually.
In addition, there are 64 temperat ure- cont rol led cel ls
within the cargo terminal’s
cold room in the warehouse.
Additonally, a vast fleet of
trucks at our hub helps to
eliminate ramp exposure.
as the crisis a wakeup
call as it exposed the
weak links in the global
pharma supply chain? What
are your suggestions to
COVID-19 has exposed a number of vulnerabilities and weak
links in the pharma supply
chain. Operational and geopolitical risks further add to this.
These challenges can be overcome with strong SOPs, quality management systemsm and
risk assessments that will lead
to smart and agile supply
chains supported by smart investments, increased supply
chain visibility, and partnerships with suppliers.
hat is the state of
to and from India? How do
you see the shifts in market
demand in recent times?
Currently, we operate 59 passenger freighters (these are
cargo-only flights) and 22
freighters weekly to India,
offer i ng more t ha n 2,800
tonnes of capacity both way,
every week. Utilising our
specialist product QR Pharma, in 2019, more than 25 per
cent of all pharma shipment
exports on our flights originated from India.
India is one of the prominent pharmaceutical markets,
already a leading country for
generic drug manufacturing.
It’s just that the demand for
pharmaceuticals into and from
India keeps growing each year.
It is anticipated that India
will be a major player during
the distribution of the COVID-19 vaccine and its components. We have a task-force
team in place looking into
various scenarios and plans,
helping us to prepare for flying a COVID-19 vaccine when
it is ready.
hat about advanced
technology deployments across the airline’s
operations that provide
real-time temperature updates and end-to-end track
and trace services?
Given the nature of pharmaceutical shipments, it is essential to maintain a seamless
cool chain during all phases of
We have a wide range of
data loggers and real-time
monitoring devices that have
been approved. Customers can
choose the device they want to
place in their shipments and
they will receive real-time temperature data and updates regarding their shipments.
times, collaboration, visibility
and transparency are becoming all the more important, a
patient-centric supply chain is
therefore critical. Standardisation initiatives, such as the
IATA CEIV program, focus on
compliance, digitalisation and
automation, which are in fact
the emerging trends amidst
o you think India
has the potential to
become a global pharma
hub in the coming years?
India’s pharmaceutical market
We have also invested in an airside
Climate Control Centre at HIA. The
2,470 sq mt transit facility has storage
capacity of 156 ULDs and dual-zoned
hat else you believe
Airways Cargo different
from its counterparts?
Our people are our greatest asset. Additionally, the infrastructure, fleet, network and solutions make the perfect combination and enable us to provide
the high-end service to our
is at the core of our business
and I believe this differentiates
us from the rest of our competition. We are always ready to
listen to our customers.
ccording to you, what
are the emerging best
practices in the pharma
An efficient supply chain is
the backbone of the pharma
industry. With the changing
has its own unique characteristics, presenting opportunities and challenges. The country is already a major player
and with the growing demand worldwide, India will
definitely become more important in times to come, as it
continues to address its supply chain challenges.
The COVID-19 crisis provides an opportunity to the
Indian pharmaceutical industry to play a very important
role in global healthcare and
potentially become a global
Through our scheduled
and charter services and an
extensive network in India,
we see ourselves well placed
to support India’s booming
pharma industry, utilising our
product QR Pharma.
CargoConnect november 2020 | 31